Insulet Corp. (NASDAQ:PODD) has received a consensus rating of “Hold” from the sixteen brokerages that are covering the company,Analyst RN reports. Two research analysts have rated the stock with a sell recommendation, six have assigned a hold recommendation and seven have assigned a buy recommendation to the company. Insulet Corporation (NASDAQ:PODD) shares after opening at $49.44 moved to $49.55 on last trade day and at the end of the day closed at $44.31. Company price to sales ratio in past twelve months was calculated as 9.91 and price to cash ratio as 16.35. Insulet Corporation (NASDAQ:PODD) showed a negative weekly performance of -6.06%.
Retrophin Inc (NASDAQ:RTRX) announced after the bell Monday that it acquired all of Manchester Pharmaceuticals’ rights, titles and interests and related trademarks outside of the U.S to certain pharmaceutical products that contain the active ingredients chenodiol. The stock is now down 0.60 on 1.3 million shares. Retrophin Inc (NASDAQ:RTRX) shares fell -9.85% in last trading session and ended the day on $19.03. RTRX its return on assets is -707.30%. Retrophin Inc (NASDAQ:RTRX) yearly performance is 269.51%.
Novadaq Technologies (NASDAQ:NVDQ) has been given an average recommendation of “Hold” by the eleven brokerages that are currently covering the stock, Analyst Ratings Network reports. One analyst has rated the stock with a sell rating, four have issued a hold rating and five have given a buy rating to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $16.14.Novadaq Technologies Inc. (NASDAQ:NVDQ) shares moved down -11.86% in last trading session and was closed at $20.81, while trading in range of $20.12-$24.09. Novadaq Technologies Inc. (NASDAQ:NVDQ) year to date performance is 26.20%.
Prothena Corp (NASDAQ:PRTA) was the target of a large increase in short interest during the month of January. As of March 14th, there was short interest totalling 824,645 shares, an increase of 35.0% from the February 28th total of 610,797 shares, Analyst Ratings.Net reports. Based on an average daily volume of 239,738 shares, the short-interest ratio is currently 3.4 days. Currently, 3.8% of the company’s shares are short sold.Prothena Corporation PLC (NASDAQ:PRTA) weekly performance is -17.85%. On last trading day company shares ended up $29.60. Prothena Corporation PLC (NASDAQ:PRTA) distance from 50-day simple moving average is -12.88%.